- Home
- WVVI vs EVAX Comparison
WVVI vs EVAX Comparison
Compare WVVI & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- EVAX
- Stock Information
- Founded
- WVVI 1983
- EVAX 2008
- Country
- WVVI United States
- EVAX Denmark
- Employees
- WVVI N/A
- EVAX N/A
- Industry
- WVVI Beverages (Production/Distribution)
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WVVI Consumer Staples
- EVAX Health Care
- Exchange
- WVVI Nasdaq
- EVAX Nasdaq
- Market Cap
- WVVI 16.5M
- EVAX 14.3M
- IPO Year
- WVVI N/A
- EVAX 2021
- Fundamental
- Price
- WVVI $3.35
- EVAX $1.68
- Analyst Decision
- WVVI
- EVAX Strong Buy
- Analyst Count
- WVVI 0
- EVAX 2
- Target Price
- WVVI N/A
- EVAX $11.00
- AVG Volume (30 Days)
- WVVI 6.6K
- EVAX 27.9K
- Earning Date
- WVVI 11-12-2024
- EVAX 10-31-2024
- Dividend Yield
- WVVI N/A
- EVAX N/A
- EPS Growth
- WVVI N/A
- EVAX N/A
- EPS
- WVVI N/A
- EVAX N/A
- Revenue
- WVVI $39,259,016.00
- EVAX $3,295,000.00
- Revenue This Year
- WVVI N/A
- EVAX $4,845.21
- Revenue Next Year
- WVVI N/A
- EVAX $30.30
- P/E Ratio
- WVVI N/A
- EVAX N/A
- Revenue Growth
- WVVI N/A
- EVAX N/A
- 52 Week Low
- WVVI $3.31
- EVAX $1.59
- 52 Week High
- WVVI $5.52
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- WVVI 43.95
- EVAX 20.75
- Support Level
- WVVI $3.33
- EVAX $1.59
- Resistance Level
- WVVI $3.52
- EVAX $2.63
- Average True Range (ATR)
- WVVI 0.15
- EVAX 0.23
- MACD
- WVVI -0.00
- EVAX -0.09
- Stochastic Oscillator
- WVVI 16.78
- EVAX 5.96
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.